Memantine, a promising drug for the prevention of neuropathic pain in rat.

N-methyl-D-aspartate (NMDA) receptor antagonists are used for post-surgery neuropathic pain but severe side-effects limit their clinical use. Memantine, when given after surgery, shows conflicting results as regard to neuropathic pain alleviation. Here memantine is administered in animals before or after spinal nerve ligation (SNL) in order to evaluate the induced antinociceptive/cognitive effects and associated molecular events, including the phosphorylation of several tyrosine (pTyr(1336), pTyr(1472)) and serine (pSer(1303)) residues in the NR2B subunit of the NMDA receptor. Spinal nerve ligated and sham animals received memantine (20mg/kg/day) or vehicle (1ml/kg/day) by intraperitoneal route. Pre-emptive protocol started 4 days before surgery and continued for 2 days post-surgery. In the post-operative protocol, the 7 day-treatment began on the day of surgery. Tests were done before and after surgery. Tactile allodynia, mechanical hyperalgesia and spatial memory were evaluated by von Frey, Randall & Selitto and Y-maze-tests respectively, and molecular events by western-blot analysis. Spinal nerve ligated animals displayed nociception, impaired memory and increased expression of the 3 phosphorylated residues. Post-operative memantine had no beneficial effect. Pre-emptive memantine prevented the development of post-surgical nociception, impairment of spatial memory and did not increase the expression of pTyr(1472)NR2B at spinal, insular and hippocampal levels. Memantine administered a few days before surgery is a promising strategy to alleviate neuropathic pain development and impairment of cognitive function in animals. The pivotal role of pTyr(1472)NR2B must be studied further, and these findings will now be challenged in patients for the prevention of postsurgical neuropathic pain.

[1]  Lei Shi,et al.  Inhibition of protein tyrosine phosphatases in spinal dorsal horn attenuated inflammatory pain by repressing Src signaling , 2013, Neuropharmacology.

[2]  T. Yaksh,et al.  Quantitative assessment of tactile allodynia in the rat paw , 1994, Journal of Neuroscience Methods.

[3]  F. López-Muñoz,et al.  Insular cortex lesion diminishes neuropathic and inflammatory pain‐like behaviours , 2011, European journal of pain.

[4]  D. Price,et al.  Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy , 1992, Brain Research.

[5]  Takeshi Kato,et al.  Effect of Memantine on the Levels of Neuropeptides and Microglial Cells in the Brain Regions of Rats with Neuropathic Pain , 2009, Journal of Molecular Neuroscience.

[6]  N. Birbaumer,et al.  Continuous brachial plexus blockade in combination with the NMDA receptor antagonist memantine prevents phantom pain in acute traumatic upper limb amputees , 2007, European journal of pain.

[7]  Memantine treatment reverses anhedonia, normalizes corticosterone levels and increases BDNF levels in the prefrontal cortex induced by chronic mild stress in rats , 2012, Metabolic Brain Disease.

[8]  M. Honda,et al.  Expectation of Pain Enhances Responses to Nonpainful Somatosensory Stimulation in the Anterior Cingulate Cortex and Parietal Operculum/Posterior Insula: an Event-Related Functional Magnetic Resonance Imaging Study , 2000, The Journal of Neuroscience.

[9]  Yi Dai,et al.  Activation of Src-Family Kinases in Spinal Microglia Contributes to Mechanical Hypersensitivity after Nerve Injury , 2006, The Journal of Neuroscience.

[10]  C.-C. Lai,et al.  Involvement of protein kinase C and Src tyrosine kinase in acute tolerance to ethanol inhibition of spinal NMDA‐induced pressor responses in rats , 2009, British journal of pharmacology.

[11]  W. Guo,et al.  Tyrosine Phosphorylation of the NR2B Subunit of the NMDA Receptor in the Spinal Cord during the Development and Maintenance of Inflammatory Hyperalgesia , 2002, The Journal of Neuroscience.

[12]  A. Hama,et al.  MK-801 blocks the development of thermal hyperalgesia in a rat model of experimental painful neuropathy , 1991, Brain Research.

[13]  A. Sood,et al.  Up-regulation of Cavβ3 Subunit in Primary Sensory Neurons Increases Voltage-activated Ca2+ Channel Activity and Nociceptive Input in Neuropathic Pain* , 2011, The Journal of Biological Chemistry.

[14]  M. Narita,et al.  Changes in function of NMDA receptor NR2B subunit in spinal cord of rats with neuropathy following chronic ethanol consumption. , 2007, Life sciences.

[15]  T. Vanderah,et al.  Differential activities of intrathecal MK-801 or morphine to alter responses to thermal and mechanical stimuli in normal or nerve-injured rats , 1997, Pain.

[16]  Dante R. Chialvo,et al.  Chronic pain patients are impaired on an emotional decision-making task , 2004, Pain.

[17]  Jin Mo Chung,et al.  An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat , 1992, PAIN.

[18]  M. Baliki,et al.  Towards a theory of chronic pain , 2009, Progress in Neurobiology.

[19]  M. Le Moal,et al.  A two-trial memory task with automated recording: study in young and aged rats , 1992, Brain Research.

[20]  C. Parsons,et al.  Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: in vitro and in vivo characterization , 1999, Neuropharmacology.

[21]  Shoji Komai,et al.  Characterization of Fyn-mediated Tyrosine Phosphorylation Sites on GluRε2 (NR2B) Subunit of theN-Methyl-d-aspartate Receptor* , 2001, The Journal of Biological Chemistry.

[22]  Jessica K. Alexander,et al.  Stress exacerbates neuropathic pain via glucocorticoid and NMDA receptor activation , 2009, Brain, Behavior, and Immunity.

[23]  Ian M. Fowler,et al.  Profound pain reduction after induction of memantine treatment in two patients with severe phantom limb pain. , 2008, Anesthesia and analgesia.

[24]  A. Dickenson,et al.  Comparison of the effects of MK-801, ketamine and memantine on responses of spinal dorsal horn neurones in a rat model of mononeuropathy , 2001, Pain.

[25]  David A. Seminowicz,et al.  MRI structural brain changes associated with sensory and emotional function in a rat model of long-term neuropathic pain , 2009, NeuroImage.

[26]  S. Harrison,et al.  Pre treatment with MK-801, a non-competitive NMDA antagonist, prevents development of mechanical hyperalgesia in a rat model of chronic neuropathy, but not in a model of chronic inflammation , 1994, Neuroscience Letters.

[27]  R. Lo,et al.  A method for measurement of analgesic activity on inflamed tissue. , 1957 .

[28]  V. Cibert-Goton,et al.  EphrinB2 induces tyrosine phosphorylation of NR2B via Src-family kinases during inflammatory hyperalgesia , 2008, Neuroscience.

[29]  G. Bennett,et al.  Neuropathic pain sensations are differentially sensitive to dextrorphan , 1994, Neuroreport.

[30]  Masahiko Watanabe,et al.  Fyn kinase‐mediated phosphorylation of NMDA receptor NR2B subunit at Tyr1472 is essential for maintenance of neuropathic pain , 2005, The European journal of neuroscience.

[31]  P. Daeninck,et al.  Pilot study of a survey to identify the prevalence of and risk factors for chronic neuropathic pain following breast cancer surgery. , 2012, Oncology nursing forum.

[32]  Petr Cvrcek.  Side effects of ketamine in the long-term treatment of neuropathic pain. , 2008, Pain medicine.

[33]  B. McEwen,et al.  Chronic stress impairs rat spatial memory on the Y maze, and this effect is blocked by tianeptine pretreatment. , 1996, Behavioral neuroscience.

[34]  H. Tozaki-Saitoh,et al.  Lyn tyrosine kinase is required for P2X4 receptor upregulation and neuropathic pain after peripheral nerve injury , 2008, Glia.

[35]  Masahiko Watanabe,et al.  Impairment of CaMKII activation and attenuation of neuropathic pain in mice lacking NR2B phosphorylated at Tyr1472 , 2010, The European journal of neuroscience.

[36]  D. Price,et al.  Intrathecal treatment with dextrorphan or ketamine potently reduces pain-related behaviors in a rat model of peripheral mononeuropathy , 1993, Brain Research.

[37]  Jon W. Johnson,et al.  Mechanism of action of memantine. , 2006, Current opinion in pharmacology.

[38]  H. Anderson,et al.  NMDA receptor antagonist treatment at the time of nerve injury prevents injury-induced changes in spinal NR1 and NR2B subunit expression and increases the sensitivity of residual pain behaviours to subsequently administered NMDA receptor antagonists , 2005, Pain.

[39]  H. Ueno,et al.  Activation of dorsal horn microglia contributes to diabetes‐induced tactile allodynia via extracellular signal‐regulated protein kinase signaling , 2008, Glia.

[40]  A. Malmberg,et al.  Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat. , 1997, The Journal of pharmacology and experimental therapeutics.

[41]  E. Eisenberg,et al.  The clinically tested N-methyl-d-aspartate receptor antagonist memantine blocks and reverses thermal hyperalgesia in a rat model of painful mononeuropathy , 1995, Neuroscience Letters.

[42]  C. Parsons,et al.  Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist—a review of preclinical data , 1999, Neuropharmacology.

[43]  M. Max,et al.  Dextromethorphan and Memantine in Painful Diabetic Neuropathy and Postherpetic Neuralgia: Efficacy and Dose-Response Trials , 2002, Anesthesiology.

[44]  M. Etienne,et al.  Phosphorylation of spinal N-methyl-d-aspartate receptor NR1 subunits by extracellular signal-regulated kinase in dorsal horn neurons and microglia contributes to diabetes-induced painful neuropathy. , 2011, European journal of pain.

[45]  Memantine (a N-Methyl-d-Aspartate Receptor Antagonist) in the Treatment of Neuropathic Pain After Amputation or Surgery: A Randomized, Double-Blinded, Cross-Over Study , 2000, Anesthesia and analgesia.

[46]  Masahiko Watanabe,et al.  Involvement of spinal phosphorylation cascade of Tyr1472-NR2B, Thr286-CaMKII, and Ser831-GluR1 in neuropathic pain , 2011, Neuropharmacology.

[47]  H. J. McQuay,et al.  Algorithm for neuropathic pain treatment: An evidence based proposal , 2005, Pain.

[48]  D. Yarnitsky,et al.  The NMDA (N‐methyl‐D‐aspartate) receptor antagonist memantine in the treatment of postherpetic neuralgia: A double‐blind, placebo‐controlled study , 1998, European journal of pain.

[49]  M. Zimmermann,et al.  Ethical guidelines for investigations of experimental pain in conscious animals , 1983, Pain.

[50]  S. Carlton,et al.  Treatment with the NMDA antagonist memantine attenuates nociceptive responses to mechanical stimulation in neuropathic rats , 1995, Neuroscience Letters.

[51]  W. Dixon,et al.  Efficient analysis of experimental observations. , 1980, Annual review of pharmacology and toxicology.

[52]  George T Grossberg,et al.  Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias , 2009, Clinical interventions in aging.

[53]  X. Gu,et al.  Tyrosine phosphorylation of the N-Methyl-D-Aspartate receptor 2B subunit in spinal cord contributes to remifentanil-induced postoperative hyperalgesia: the preventive effect of ketamine , 2009, Molecular pain.

[54]  R. Lu,et al.  Low-Dose Memantine Attenuated Morphine Addictive Behavior Through its Anti-Inflammation and Neurotrophic Effects in Rats , 2011, Journal of Neuroimmune Pharmacology.

[55]  S. Matsumura,et al.  Involvement of Tyr1472 phosphorylation of NMDA receptor NR2B subunit in postherpetic neuralgia in model mice , 2012, Molecular pain.

[56]  Clifford J. Woolf,et al.  The induction and maintenance of central sensitization is dependent on N-methyl-d-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states , 1991, Pain.

[57]  J. Eisenach,et al.  Intrathecal Morphine Reduces Allodynia after Peripheral Nerve Injury in Rats via Activation of a Spinal A1 Adenosine Receptor , 2005, Anesthesiology.

[58]  Howard L Fields,et al.  Glutamatergic activation of anterior cingulate cortex produces an aversive teaching signal , 2004, Nature Neuroscience.

[59]  Edward J Gracely,et al.  Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome. , 2004, Pain medicine.

[60]  V. Yuferov,et al.  Effects of memantine alone and with acute 'binge' cocaine on hypothalamic-pituitary-adrenal activity in the rat. , 1998, European journal of pharmacology.

[61]  Xiao Xiao,et al.  NMDA NR2A and NR2B receptors in the rostral anterior cingulate cortex contribute to pain-related aversion in male rats , 2009, PAIN.

[62]  M. Iadarola,et al.  Spinal cord NR1 serine phosphorylation and NR2B subunit suppression following peripheral inflammation , 2005, Molecular pain.

[63]  P. Schwenkreis,et al.  Efficacy of the NMDA-receptor antagonist memantine in patients with chronic phantom limb pain – results of a randomized double-blinded, placebo-controlled trial , 2003, Pain.

[64]  V. Gutierrez,et al.  Participation of neuronal nitric oxide synthase in experimental neuropathic pain induced by sciatic nerve transection. , 2010, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.